ClassID:

21647

A61K2300/00 - page 27 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#7801
20110257236
2011-10-20

SOLID SOLUTION OF VALINE, ISOLEUCINE, LEUCINE AND ITS MANUFACTURING METHOD

#7802
20110257229
2011-10-20

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#7803
20110257227
2011-10-20

Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate

#7804
20110257206
2011-10-20

Combinations of Therapeutic Agents for Treating Cancer

#7805
20110257203
2011-10-20

Inhibitors of Bruton's tyrosine kinase

#7806
20110257202
2011-10-20

Therapeutic Compositions and Methods for Treating Chronic Kidney Disease Associated with a Metabolic Imbalance

#7807
20110257196
2011-10-20

Compounds for treatment of cancer

#7808
20110257192
2011-10-20

COMPOUND FOR TREATMENT OF RESPIRATORY CONDITION OR DISEASE

#7809
20110257188
2011-10-20

Compositions and methods for the treatment of nasal conditions

#7810
20110257181
2011-10-20

Pyridazinone derivatives

#7811
20110257174
2011-10-20

Chromenone analogs as sirtuin modulators

#7812
20110257167
2011-10-20

Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors

#7813
20110257138
2011-10-20

MONOTERPENES FOR TREATING RESPIRATORY TRACT DISEASES, IN PARTICULAR BRONCHOPULMONARY DISEASES

#7814
20110257134
2011-10-20

CO-CRYSTALS OF TRAMADOL AND NSAIDs

#7815
20110257132
2011-10-20

CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE

#7816
20110257126
2011-10-20

Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy

#7817
20110257120
2011-10-20

BETA-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B

#7818
20110257113
2011-10-20

Method for inducing a TRIF-bias

#7819
20110257110
2011-10-20

Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition

#7820
20110257094
2011-10-20

Anti periodontitis-causing microorganism agent and medical or dental materials using the same

#7821
20110257093
2011-10-20

Therapies for acute renal failure

#7822
20110257088
2011-10-20

Low-concentration nutritional composition

#7823
20110257085
2011-10-20

Crystal forms of saxagliptin and processes for preparing same

#7824
20110257079
2011-10-20

Parenteral combination therapy for infective conditions with drug resistant bacterium

#7825
20110257078
2011-10-20

Antibacterial combination therapy for the treatment of gram positive bacterial infections

#7826
20110256522
2011-10-20

Arginine-containing compositions and methods for treating red blood cells

#7827
20110256249
2011-10-20

Hair and scalp care formulations for treating and preventing acne and related skin conditions

#7828
20110256248
2011-10-20

Antioxidant compositions and methods thereto

#7829
20110256241
2011-10-20

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#7830
20110256240
2011-10-20

Combination Therapy

#7831
20110256239
2011-10-20

INGESTIBLE HAIR AND FINGER NAIL GROWTH PROMOTER AND METHOD

#7832
20110256237
2011-10-20

METHODS AND COMPOSITIONS FOR TREATING ACNE VULGARIS AND ACNE ROSACEA

#7833
20110256236
2011-10-20

Enhancement of the Anti-Leukemic Effect of Thalidomide

#7834
20110256226
2011-10-20

Opioid agonist formulations with releasable and sequestered antagonist

#7835
20110256221
2011-10-20

PHARMACEUTICAL FORMULATIONS OF OLMESARTAN

#7836
20110256220
2011-10-20

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

#7837
20110256215
2011-10-20

NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY

#7838
20110256211
2011-10-20

Contraceptive transdermal delivery of hormones

#7839
20110256210
2011-10-20

Contraceptive transdermal delivery of hormones

#7840
20110256209
2011-10-20

Skin patch for improving menstrual

#7841
20110256161
2011-10-20

METHODS FOR ENHANCING IMMUNE RESPONSE

#7842
20110256148
2011-10-20

Methods for treating hypercholesterolemia using antibodies to PCSK9

#7843
20110256136
2011-10-20

Complement inhibitors for treatment of injury from intracerebral hemorrhage

#7844
20110256130
2011-10-20

METHODS OF TREATING INFLAMMATORY DISORDERS

#7845
20110256124
2011-10-20

METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE

#7846
20110256116
2011-10-20

Low/high dose probiotic supplements and methods of their use

#7847
20110256098
2011-10-20

Immunotherapy for chronic hepatitis C virus infection

#7848
20110256096
2011-10-20

Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases

#7849
20110256082
2011-10-20

Antiperspirants and deodorants

#7850
20110252487
2011-10-13

Compositions, methods and animal models for screening therapeutics for TH2-type disease

#7851
20110251279
2011-10-13

Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration

#7852
20110251276
2011-10-13

BIOLOGICAL OIL COMPOSITION, FORMULATIONS COMPRISING THE OIL COMPOSITION, AND USE THEREOF TO PREVENT OR TREAT CARDIOVASCULAR DISEASE

#7853
20110251274
2011-10-13

Natural Vitamin E Compositions with Superior Antioxidant Potency

#7854
20110251271
2011-10-13

Cosmetic composition with anti-free radical activity

#7855
20110251265
2011-10-13

POLYAMINE-CONTAINING POLYMERS AND METHODS OF SYNTHESIS AND USE

#7856
20110251250
2011-10-13

Use of dimiracetam in the treatment of chronic pain

#7857
20110251245
2011-10-13

Solid pharmaceutical composition comprising amlodipine and losartan

#7858
20110251239
2011-10-13

COMBINATION THERAPY FOR THE TREATMENT OF DEMENTIA

#7859
20110251235
2011-10-13

STABLE LAQUINIMOD PREPARATIONS

#7860
20110251208
2011-10-13

Phosphodiesterase type III (PDE III) inhibitors or CA-sensitizing agents for the treatment of hypertrophic cardiomyopathy

#7861
20110251163
2011-10-13

Contraceptive transdermal delivery of hormones

#7862
20110251157
2011-10-13

Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid

#7863
20110251155
2011-10-13

Methods of using diacerein as an adjunctive therapy for diabetes

#7864
20110251151
2011-10-13

Combination compositions for reducing intraocular pressure

#7865
20110251149
2011-10-13

Methods and low dose regimens for treating red blood cell disorders

#7866
20110251147
2011-10-13

Compositions Comprising Quinolone and Methods for Treating or Controlling Infections

#7867
20110251145
2011-10-13

Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

#7868
20110251141
2011-10-13

COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONS

#7869
20110251134
2011-10-13

COMBINATION OF (A) A DNA TOPOSOMERASE INHIBITOR AND (B) AN IAP INHIBITOR

#7870
20110250317
2011-10-13

INFANT OR FOLLOW-ON FORMULA

#7871
20110250304
2011-10-13

Cosmetic composition with anti-free radical activity

#7872
20110250303
2011-10-13

Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium

#7873
20110250302
2011-10-13

Composition for Preventing Hair Loss and Promoting Hair Regrowth

#7874
20110250298
2011-10-13

Composition to help protect a user against liver damage from alcohol consumption

#7875
20110250297
2011-10-13

Treatment of Hyperproliferative Disorders Using Cardiac Glycosides

#7876
20110250296
2011-10-13

REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS

#7877
20110250293
2011-10-13

Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water

#7878
20110250292
2011-10-13

COMPOSITION FOR IMPROVING RADIOTHERAPY FOR CANCER

#7879
20110250291
2011-10-13

Use of arsenic for cancer therapy protection

#7880
20110250273
2011-10-13

COMPOSITIONS OF PROTON PUMP INHIBITORS, KITS AND METHODS OF THEIR USE TO TREAT DIABETES

#7881
20110250271
2011-10-13

SPACED DRUG DELIVERY SYSTEM

#7882
20110250270
2011-10-13

Compositions containing a capillary-active system with application-relevant diffferentiability and their use

#7883
20110250268
2011-10-13

Compositions and methods for inhibiting gastric acid secretion

#7884
20110250258
2011-10-13

Tumor specific delivery of therapeutic agents via liposomase

#7885
20110250242
2011-10-13

ARFORMOTEROL AND TIOTROPIUM COMPOSITIONS AND METHODS FOR USE

#7886
20110250240
2011-10-13

IMMUNE ENHANCING COMPOSITIONS AND METHODS OF USE THEREOF

#7887
20110250238
2011-10-13

SYSTEM FOR THE COLON DELIVERY OF DRUGS SUBJECT TO ENZYME DEGRADATION AND/OR POORLY ABSORBED IN THE GASTROINTESTINAL TRACT

#7888
20110250218
2011-10-13

Disease-Associated Antigens and Methods of Use Thereof

#7889
20110250212
2011-10-13

Therapy procedure for drug delivery for trigeminal pain

#7890
20110250197
2011-10-13

PHARMACEUTICAL COMBINATION

#7891
20110250196
2011-10-13

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

#7892
20110250194
2011-10-13

Treatment with anti-ErbB2 antibodies

#7893
20110250191
2011-10-13

Composition for enhancing physical performance

#7894
20110250183
2011-10-13

Combination therapy for treatment of patients with neurological disorders and cerebral infarction

#7895
20110250182
2011-10-13

Angiogenesis using placental stem cells

#7896
20110250176
2011-10-13

Combinations of hepatitis C virus inhibitors

#7897
20110250173
2011-10-13

Methods and compositions for inhibition of Treg cells

#7898
20110250172
2011-10-13

Hepatitis C virus inhibitors

#7899
20110250170
2011-10-13

Immunocytokines for tumour therapy with chemotherapeutic agents

#7900
20110250166
2011-10-13

Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer

#7901
20110250142
2011-10-13

COMBINATION THERAPIES FOR TREATMENT OF HYPERTENSION AND COMPLICATIONS IN PATIENTS WITH DIABETES OR METABOLIC SYNDROME

#7902
20110247613
2011-10-13

ALBUTEROL AND IPRATROPIUM INHALATION SOLUTION, SYSTEM, KIT AND METHOD FOR RELIEVING SYMPTOMS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#7903
20110246399
2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#7904
20110245867
2011-10-06

Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis

#7905
20110245804
2011-10-06

Methods and Compositions to Facilitate Repair of Avascular Tissue

#7906
20110245772
2011-10-06

FOCAL CALCIUM CHANNEL MODULATION

#7907
20110245759
2011-10-06

Methods of Treating An Infection with Nitric Oxide

#7908
20110245757
2011-10-06

Method for treating chronic wounds with an extracellular polymeric substance solvating system

#7909
20110245577
2011-10-06

COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER

#7910
20110245501
2011-10-06

Substituted Tetracycline Compounds as Synergistic Antifungal Agents

#7911
20110245345
2011-10-06

Topical Treatment Formulation of Natural Ingredients for Enhancing Sexual Response

#7912
20110245323
2011-10-06

RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses

#7913
20110245317
2011-10-06

USE OF ORGANIC COMPOUNDS

#7914
20110245309
2011-10-06

N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION

#7915
20110245307
2011-10-06

Methods for Alzheimer's Disease Treatment and Cognitive Enhancement

#7916
20110245303
2011-10-06

Heteroalkyl biphenyl antagonists of prostaglandin Dreceptors

#7917
20110245302
2011-10-06

Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same

#7918
20110245301
2011-10-06

Solid pharmaceutical composition comprising amlodipine and losartan with improved stability

#7919
20110245294
2011-10-06

METHODS OF IMPROVING QUALITY OF SLEEP

#7920
20110245293
2011-10-06

PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST

#7921
20110245287
2011-10-06

Hybrid opioid compounds and compositions

#7922
20110245278
2011-10-06

Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith

#7923
20110245256
2011-10-06

Use of a PKC inhibitor

#7924
20110245254
2011-10-06

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES

#7925
20110245229
2011-10-06

Dihydropyrazolopyrimidinone derivatives

#7926
20110245212
2011-10-06

Methods of alleviating the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder

#7927
20110245211
2011-10-06

Method for contraception

#7928
20110245208
2011-10-06

Compositions and methods for the treatment of somatosensory disorders

#7929
20110245202
2011-10-06

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIS

#7930
20110245193
2011-10-06

Combination compositions for reducing intraocular pressure

#7931
20110245191
2011-10-06

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

#7932
20110245188
2011-10-06

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR CONDITIONS

#7933
20110245185
2011-10-06

APO-2 ligand/trail formulations

#7934
20110245184
2011-10-06

TREATMENT OF SURGICAL ADHESIONS

#7935
20110245177
2011-10-06

METHOD FOR TOPICAL TREATMENT OF EYE DISEASE AND COMPOSITION AND DEVICE FOR SAID TREATMENT

#7936
20110245158
2011-10-06

High protein supplement

#7937
20110245156
2011-10-06

NOVEL ANTIVIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

#7938
20110245154
2011-10-06

Methods and Compositions for Treating Viral or Virally-Induced Conditions

#7939
20110245149
2011-10-06

Methods to prevent and treat diseases

#7940
20110245103
2011-10-06

PREDICTING RESPONSE TO A HER INHIBITOR

#7941
20110244478
2011-10-06

Methods and compositions for treating bleeding disorders

#7942
20110244058
2011-10-06

Compositions and methods for treatment of pulmonary diseases and conditions

#7943
20110244057
2011-10-06

COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS

#7944
20110244045
2011-10-06

Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation

#7945
20110244043
2011-10-06

Controlled releasing composition

#7946
20110243984
2011-10-06

Composition for treatment of diabetes mellitus and a preparation and an use thereof

#7947
20110243965
2011-10-06

Antibodies against domains of laminin-332

#7948
20110243964
2011-10-06

TREATMENT OF ORTHOPEDIC CONDITIONS

#7949
20110243956
2011-10-06

METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY

#7950
20110243947
2011-10-06

Antibodies against CSF-1R

#7951
20110243937
2011-10-06

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#7952
20110243933
2011-10-06

Perifosine and capecitabine as a combined treatment for cancer

#7953
20110243927
2011-10-06

METHODS OF INHIBITING TUMOR GROWTH USING BETA 5 INTEGRIN ANTAGONISTS

#7954
20110243924
2011-10-06

NOVEL METHODS

#7955
20110243921
2011-10-06

PREVENTION AND TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS

#7956
20110243918
2011-10-06

TOPICAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

#7957
20110243913
2011-10-06

Biomaterial Compositions and Methods of Use

#7958
20110243894
2011-10-06

METHODS OF TREATING HEPATITIS C VIRUS INFECTION

#7959
20110243890
2011-10-06

Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus

#7960
20110243879
2011-10-06

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#7961
20110243856
2011-10-06

Permeable mixtures, methods and compositions for the skin

#7962
20110240512
2011-10-06

Antibiotic Formulations Providing Reduced Gastrointestinal Side Effects and Clostridium difficile Infection Relapse, and Related Methods

#7963
20110240012
2011-10-06

RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS

#7964
20110237858
2011-09-29

Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues

#7965
20110237677
2011-09-29

Inhibitors

#7966
20110237674
2011-09-29

TOPICAL NSAID COMPOSITIONS HAVING SENSATE COMPONENT

#7967
20110237673
2011-09-29

Novel NIDDM Regimen

#7968
20110237663
2011-09-29

Method for treating Philadelphia-negative myeloproliferative syndromes

#7969
20110237660
2011-09-29

Oral composition

#7970
20110237616
2011-09-29

PHEHYLEPHRINE FORMULATIONS WITH IMPROVEDS STABILITY

#7971
20110237611
2011-09-29

Chemical permeation enhancers enhance nerve blockade by toxins

#7972
20110237602
2011-09-29

Method for treating schizophrenia and related diseases

#7973
20110237560
2011-09-29

MODULATING AND/OR DETECTING ACTIVATION INDUCED DEAMINASE AND METHODS OF USE THEREOF

#7974
20110237558
2011-09-29

Stabilized composition for treating psoriasis

#7975
20110237555
2011-09-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#7976
20110237554
2011-09-29

Combination therapies: inhibitors of GABA transaminase and NKCC1

#7977
20110237548
2011-09-29

SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME USING OMEGA CHOLINE

#7978
20110237547
2011-09-29

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FUNGAL INFECTIONS

#7979
20110237546
2011-09-29

Method for treating a mammal by administration of a compound having the ability to release CO

#7980
20110237540
2011-09-29

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

#7981
20110237532
2011-09-29

1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL

#7982
20110237530
2011-09-29

Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug

#7983
20110237525
2011-09-29

Method of ameliorating oxidative stress and supplementing the diet

#7984
20110237519
2011-09-29

Method of reversing carboplatin resistance by inhibition of HGFIN

#7985
20110237512
2011-09-29

Methods for treating bleeding disorders using sulfated polysaccharides

#7986
20110237505
2011-09-29

Compositions and methods for treating obesity and diabetes

#7987
20110237497
2011-09-29

COMPOSITIONS OF A V-ATPASE INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID RECEPTOR LIGAND AND METHODS OF USE

#7988
20110237496
2011-09-29

ANTINECROTIC ACTIVITY OF ALPHA 1-ANTITRYPSIN

#7989
20110236513
2011-09-29

SUBSTANCES CAPABLE OF POTENTIATING LAMININ 5 PRODUCTIVITY IN EPIDERMAL CELLS AND THEIR USE

#7990
20110236511
2011-09-29

Herbal formulations

#7991
20110236510
2011-09-29

PREGNANE GLYCOSIDE COMPOSITIONS AND CARALLUMA EXTRACT PRODUCTS AND USES THEREOF

#7992
20110236509
2011-09-29

Topical composition comprising extracts of and or

#7993
20110236507
2011-09-29

Inhibition of DNA polymerases to augment chemotherapeutic and antimicrobial agents

#7994
20110236506
2011-09-29

PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID AND HYDROXYCITRIC ACID AS ACTIVE INGREDIENTS

#7995
20110236504
2011-09-29

VERSATILE DISINFECTANT

#7996
20110236503
2011-09-29

Topical Skincare Composition

#7997
20110236502
2011-09-29

Vitamin Strip (V1)

#7998
20110236499
2011-09-29

Dermal compositions containing gorgonian extract

#7999
20110236491
2011-09-29

TOPICAL ANTI-INFLAMMATORY COMPOSITION

#8000
20110236490
2011-09-29

TREATMENT OR PREVENTION OF VIRAL INFECTION BY CHLORINATION

#8001
20110236488
2011-09-29

Herbal formulation for prevention and treatment of diabetes and associated complications

#8002
20110236481
2011-09-29

Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity

#8003
20110236480
2011-09-29

Prebiotic formulations and methods of use

#8004
20110236478
2011-09-29

Co-crystals and pharmaceutical formulations comprising the same

#8005
20110236477
2011-09-29

Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof

#8006
20110236476
2011-09-29

PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME

#8007
20110236472
2011-09-29

Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

#8008
20110236461
2011-09-29

METHODS FOR STIMULATING CHONDROGENESIS UTILIZING A POTASSIUM CHANNEL INHIBITOR

#8009
20110236457
2011-09-29

Micronized device for the delivery of biologically active molecules and methods of use thereof

#8010
20110236437
2011-09-29

Nanoparticles and methods of use

#8011
20110236431
2011-09-29

TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF

#8012
20110236430
2011-09-29

METHOD FOR CONTROLLING TOXICITY OF METALLIC PARTICLE AND LOW-TOXICITY COMPOSITE OF METALLIC NANOPARTICLE AND INORGANIC CLAY

#8013
20110236428
2011-09-29

COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES

#8014
20110236414
2011-09-29

Bacterial Polysaccharide-Polypeptide Conjugate Compositions

#8015
20110236413
2011-09-29

Methods and compositions to reduce fat gain, promote weight loss in animals

#8016
20110236405
2011-09-29

COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE

#8017
20110236392
2011-09-29

Treatment of preterm labor with toll-like receptor 9 antagonists

#8018
20110236382
2011-09-29

IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION

#8019
20110236379
2011-09-29

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#8020
20110236368
2011-09-29

ORAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

#8021
20110236365
2011-09-29

Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage

#8022
20110236358
2011-09-29

COMPOSITION COMPRISING ISOFLAVONES

#8023
20110236351
2011-09-29

Therapeutic Regimen Comprising PEG-Interferon, Ribavirin and VX-950 for the Treatment of Hepatitis

#8024
20110236350
2011-09-29

ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES

#8025
20110236346
2011-09-29

Compositions and methods for treatment of radiation exposure

#8026
20110236322
2011-09-29

ORAL PH AND BUFFERING CAPACITY MODIFIERS

#8027
20110236305
2011-09-29

METHODS FOR PROTECTING AND REGENERATING BONE MARROW USING CXCR3 AGONISTS AND ANTAGONISTS

#8028
20110236256
2011-09-29

Cold sterilization of tissue engineering scaffolds with compressed carbon dioxide

#8029
20110233469
2011-09-29

Leucine/Peptide Composition and Method of Formulation

#8030
20110230813
2011-09-22

Process for metabolic control and high solute clearance and solutions for use therein

#8031
20110230560
2011-09-22

Synergetic composition comprising flavouring substances and organic acids and use thereof

#8032
20110230549
2011-09-22

Method for the treatment of constipation

#8033
20110230534
2011-09-22

Composition for local anesthesia

#8034
20110230513
2011-09-22

Pharmaceutical compositions for treatment of Parkinsons disease

#8035
20110230512
2011-09-22

Pharmaceutical composition

#8036
20110230504
2011-09-22

ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP

#8037
20110230501
2011-09-22

Pharmaceutical compositions for the treatment of diabetes mellitus

#8038
20110230473
2011-09-22

Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus

#8039
20110230466
2011-09-22

Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it

#8040
20110230454
2011-09-22

(aza)indole derivative and use thereof for medical purposes

#8041
20110230448
2011-09-22

Treatment and/or Prevention of Non-Viral Epithelial Damage

#8042
20110230444
2011-09-22

PHARMACEUTICAL COMBINATION COMPRISING A HSP 90 INHIBITOR AND A MTOR INHIBITOR

#8043
20110230435
2011-09-22

Methods and compositions for treating obesity and related disorders

#8044
20110230434
2011-09-22

Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury

#8045
20110230432
2011-09-22

COMPOSITIONS AND KITS FOR TREATING INFLUENZA

#8046
20110230431
2011-09-22

FOSFOMYCIN/TOBRAMYCIN COMBINATIONS FOR THE TREATMENT AND PREVENTION OF OPHTHALMIC, OTOLOGICAL AND DERMATOLOGICAL INFECTIONS

#8047
20110230424
2011-09-22

OPHTHALMIC SOLUTIONS, INCLUDING CONTACT LENS CARE AND EYE DROPS COMPRISING CARNOSINE, PREFERABLY IN COMBINATION WITH DEXPANTHENOL AND/OR HYALURONIC ACID

#8048
20110230423
2011-09-22

THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER

#8049
20110230418
2011-09-22

Anticancer agent

#8050
20110229871
2011-09-22

NUCLEOSIDE-CONTAINING COMPOSITIONS AND METHODS FOR TREATING RED BLOOD CELLS

#8051
20110229598
2011-09-22

Enhanced lactoperoxidase system for treatment of milk products

#8052
20110229587
2011-09-22

Calcium Supplements for the Treatment of Diabetes

#8053
20110229585
2011-09-22

Nutrient compositions and methods for enhanced effectiveness of the immune system

#8054
20110229584
2011-09-22

Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm

#8055
20110229575
2011-09-22

DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS

#8056
20110229571
2011-09-22

Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker

#8057
20110229569
2011-09-22

Compositions exhibiting delayed transit through the gastrointestinal tract

#8058
20110229567
2011-09-22

Solid pharmaceutical composition

#8059
20110229566
2011-09-22

Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof

#8060
20110229565
2011-09-22

Drug Delivery Composition Comprising a Self-Assembled Gelator

#8061
20110229563
2011-09-22

Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity

#8062
20110229561
2011-09-22

Extended release pharmaceutical composition of entacapone or salts thereof

#8063
20110229558
2011-09-22

AGENT FOR TREATING MYELOFIBROSIS

#8064
20110229526
2011-09-22

FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS

#8065
20110229514
2011-09-22

VACCINE AND IMMUNIZATION METHOD USING PLASMODIUM ANTIGEN 2

#8066
20110229499
2011-09-22

METHOD FOR TREATMENT OF VASCULAR HYPERPERMEABILITY

#8067
20110229493
2011-09-22

Neuregulin antagonists and use thereof in treating cancer

#8068
20110229478
2011-09-22

ERBB3 BASED METHODS AND COMPOSITIONS FOR TREATING NEOPLASMS

#8069
20110229477
2011-09-22

Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy

#8070
20110229469
2011-09-22

METHODS FOR THE TREATMENT OF CANCER

#8071
20110229468
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#8072
20110229467
2011-09-22

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

#8073
20110229465
2011-09-22

COMPOSITION FOR TREATING DISEASE

#8074
20110229452
2011-09-22

Ophthalmic Surgical Irrigating Solutions Containing Hyaluronidase

#8075
20110229446
2011-09-22

Method and composition to relieve sexual discomfort and improve vaginal health

#8076
20110229438
2011-09-22

METHOD OF INHIBITING HEPATITUS C VIRUS BY COMBINATION OF A 5,6-DIHYDRO-1H-PYRIDIN-2-ONE AND ONE OR MORE ADDITIONAL ANTIVIRAL COMPOUNDS

#8077
20110229437
2011-09-22

Method of Treating Asthma with Antiviral Agents

#8078
20110229436
2011-09-22

METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION DURING ASSISTED REPRODUCTION IN A SUBJECT

#8079
20110229433
2011-09-22

USE OF MODIFIED INTERLEUKIN-8 PROTEINS FOR TREATING REPERFUSION INJURY OR TRANSPLANT REJECTION

#8080
20110229419
2011-09-22

CANKER SORE PREVENTION AND HEALING

#8081
20110229411
2011-09-22

USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT

#8082
20110229408
2011-09-22

SODIUM-IODIDE SYMPORTER GENE REPRESSOR BINDING SITE

#8083
20110229406
2011-09-22

Material and methods for treating or preventing HER-3 associated diseases

#8084
20110224608
2011-09-15

Compound for local deletion of tumors

#8085
20110224599
2011-09-15

Combination of an oxidant and a photoactivator for the healing of wounds

#8086
20110224303
2011-09-15

Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders

#8087
20110224302
2011-09-15

Difluorophenyldiacylhydrazide derivatives

#8088
20110224285
2011-09-15

Oligomeric compounds for the modulation of HIF-1α expression

#8089
20110224245
2011-09-15

Treatment Of Neurological Disorders Using Huperzine

#8090
20110224242
2011-09-15

STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES

#8091
20110224240
2011-09-15

METHODS OF TREATING CANCER AND RELATED DISEASES

#8092
20110224236
2011-09-15

Treatment for pulmonary hypertension

#8093
20110224235
2011-09-15

INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS

#8094
20110224227
2011-09-15

HEMATOPOIETIC PROTECTION AGAINST CHEMOTHERAPEUTIC COMPOUNDS USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS

#8095
20110224196
2011-09-15

TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT

#8096
20110224179
2011-09-15

Medicament and method of diagnosis for treating subclinical Cushing's syndrome

#8097
20110224178
2011-09-15

Composition and method for treating erectile dysfunction

#8098
20110224176
2011-09-15

Lyophilized Cake Formulations

#8099
20110224150
2011-09-15

METHODS FOR EFFECTING REGRESSION OF TUMOR MASS AND SIZE IN A METASTASIZED TUMOR

#8100
20110224147
2011-09-15

METHODS AND COMPOSITIONS